Molecular pathology of myelodysplastic syndromes: Biology of medullary stromal and hematopoietic cells (Review)

  • Authors:
    • Masanobu Kitagawa
    • Morito Kurata
    • Kouhei Yamamoto
    • Shinya Abe
    • Shiho Suzuki
    • Shigeaki Umeda
  • View Affiliations

  • Published online on: May 16, 2011     https://doi.org/10.3892/mmr.2011.493
  • Pages: 591-596
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Myelodysplastic syndromes (MDS) have been defined as a disease entity based on clinical features and morphological findings. Despite similarities in clinical manifestations, genetic abnormalities occurring in hematopoietic cells are heterogeneous among the syndromes. However, recent investigations have revealed that there are common biological events in the bone marrow of MDS cases. Most notably, excessive apoptosis of hematopoietic cells was observed to be induced by the bone marrow microenvironment. The apoptosis was mediated by paracrine as well as autocrine factors, suggesting that medullary stromal and hematopoietic cells play a role in the pathology of disease. Pro-inflammatory cytokines, such as TNFα, in the bone marrow microenvironment are predominantly paracrine mediators of apoptosis. Regarding autocrine stimulation mechanisms, it has recently been shown that the deregulation of ribosomal protein is capable of initiating a stress response in the hematopoietic cell through a p53-mediated signaling pathway. Thus, both the stromal cells of the bone marrow microenvironment and hematopoietic cells themselves possess a common and characteristic biology in this heterogeneous disease entity.

Related Articles

Journal Cover

July-August 2011
Volume 4 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kitagawa M, Kurata M, Yamamoto K, Abe S, Suzuki S and Umeda S: Molecular pathology of myelodysplastic syndromes: Biology of medullary stromal and hematopoietic cells (Review). Mol Med Rep 4: 591-596, 2011.
APA
Kitagawa, M., Kurata, M., Yamamoto, K., Abe, S., Suzuki, S., & Umeda, S. (2011). Molecular pathology of myelodysplastic syndromes: Biology of medullary stromal and hematopoietic cells (Review). Molecular Medicine Reports, 4, 591-596. https://doi.org/10.3892/mmr.2011.493
MLA
Kitagawa, M., Kurata, M., Yamamoto, K., Abe, S., Suzuki, S., Umeda, S."Molecular pathology of myelodysplastic syndromes: Biology of medullary stromal and hematopoietic cells (Review)". Molecular Medicine Reports 4.4 (2011): 591-596.
Chicago
Kitagawa, M., Kurata, M., Yamamoto, K., Abe, S., Suzuki, S., Umeda, S."Molecular pathology of myelodysplastic syndromes: Biology of medullary stromal and hematopoietic cells (Review)". Molecular Medicine Reports 4, no. 4 (2011): 591-596. https://doi.org/10.3892/mmr.2011.493